STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
20 hedge funds and large institutions have $1.57M invested in Statera Biopharma, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$569K |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$501K |
| 3 |
VKH
3
Virtu KCG Holdings
New York
|
$154K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$46K |
| 5 |
5
BlackRock
New York
|
$43K |
Top Sellers
No sellers this quarter
